Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells-Reference-Cited by-同舟云学术

Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells

Published:2018-02-23 Issue:2 Volume:50 Page:81-91
ISSN:0145-479X
Container-title:Journal of Bioenergetics and Biomembranes
language:en
Short-container-title:J Bioenerg Biomembr

Author:

Faria Robson Xavier^ORCID,Gonzaga Daniel Tadeu Gomes,Pacheco Paulo Anastácio Furtado,Souza André Luis Almeida,Ferreira Vitor Francisco,da Silva Fernando de Carvalho

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology

Link

http://link.springer.com/article/10.1007/s10863-018-9746-z/fulltext.html

Reference50 articles.

1. Andrade P, Galo OA, Carvalho MR, Lopes CD, Carneiro ZA, Sesti-Costa R, de Melo EB, Silva JS, Carvalho I (2015) 1,2,3-Triazole-based analogue of benzonidazole displays remarkable activity against Trypanosoma cruzi. Bioorg Med Chem 23:6815–6826. https://doi.org/10.1016/j.bmc.2015.10.008

2. Bahia MT, Andrade IM, Martins TAF, Nascimento AFS, Diniz LF, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I (2012) Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Negl Trop Dis 6:e1870. https://doi.org/10.1371/journal.pntd.0001870

3. Becerra MC, Guiñazú N, Hergert LY, Pellegrini A, Mazzieri MR, Gea S, Albesa I (2012) In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms. Exp Parasitol 131:57–62. https://doi.org/10.1016/j.exppara.2012.02.028

4. Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52–e54. https://doi.org/10.1086/605091

5. Boechat N, Ferreira VF, Ferreira SB, de Lourdes G, Ferreira M, de C da Silva F, Bastos MM, Dos S Costa M, Lourenço MC, Pinto AC, Krettli AU, Aguiar AC, Teixeira BM, da Silva NV, Martins PR, Bezerra FA, Camilo AL, da Silva GP, Costa CC (2011) Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (atccATCC 27294) strain. J Med Chem 54:5988–5999. https://doi.org/10.1021/jm2003624

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion complex of O-allyl-lawsone with 2-hydroxypropyl-β-cyclodextrin: Preparation, physical characterization, antiparasitic and antifungal activity;Journal of Bioenergetics and Biomembranes;2023-06

2. Structural Insight into Privileged Heterocycles as Anti-Trypanosoma cruzi and brucei Agents;Current Topics in Medicinal Chemistry;2023-04

3. Rotenone enhances antifungal activity of novel pyrazoles against Candida spp.;European Journal of Medicinal Chemistry Reports;2022-08

4. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents;Bioorganic Chemistry;2021-11

5. Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi;Pharmaceuticals;2021-07-01